MeSH D016908 - gram-positive bacterial infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001424:Bacterial infections
D016908:Â
Gram-positive bacterial infections
D000193:Actinomycetales infections
D003015:Clostridium infections
D004889:Erysipelothrix infections
D008088:Listeriosis
D013203:Staphylococcal infections
D013290:Streptococcal infections
D016863:Bacillaceae infections
0 Companies
0 Drugs
Success rate
D039941:Bifidobacteriales infections
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Chlorhexidine | Microderm |  | 1991-04-15 |  |  |
| Chlorhexidine | Prevacare |  | 1992-01-28 |  |  | |
| 3M | Chlorhexidine | Avagard |  | 2001-06-07 |  |  |
| Chlorhexidine | Peridex |  | 1986-08-13 |  |  | |
| Chlorhexidine | Soluprep | 2029-07-26 | 2018-08-08 |  |  | |
| Merck & Co | Daptomycin | Cubicin |  | 2006-01-19 | $152 M | Y2020 |
| Xttrium Laboratories | Chlorhexidine | Chlorhexidine |  | 2009-06-18 |  |  |
| Chlorhexidine | Exidine |  | 1984-12-24 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
11%1/9
Phase 2
75%6/8
Phase 3
58%14/24
Approved: 10Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use